Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis

Simple item page
dc.contributor.authorCamargo, M. Constanza
dc.contributor.authorKim, Woo-Ho
dc.contributor.authorChiaravalli, Anna Maria
dc.contributor.authorKim, Kyoung-Mee
dc.contributor.authorCorvalan, Alejandro H.
dc.contributor.authorMatsuo, Keitaro
dc.contributor.authorYu, Jun
dc.contributor.authorSung, Joseph J. Y.
dc.contributor.authorHerrera-Goepfert, Roberto
dc.contributor.authorMeneses-Gonzalez, Fernando
dc.contributor.authorKijima, Yuko
dc.contributor.authorNatsugoe, Shoji
dc.contributor.authorLiao, Linda M.
dc.contributor.authorLissowska, Jolanta
dc.contributor.authorKim, Sung
dc.contributor.authorHu, Nan
dc.contributor.authorGonzalez, Carlos A.
dc.contributor.authorYatabe, Yashushi
dc.contributor.authorKoriyama, Chihaya
dc.contributor.authorHewitt, Stephen M.
dc.contributor.authorAkiba, Suminori
dc.contributor.authorGulley, Margaret L.
dc.contributor.authorTaylor, Philip R.
dc.contributor.authorRabkin, Charles S.
dc.date.accessioned2025-01-23T21:48:30Z
dc.date.available2025-01-23T21:48:30Z
dc.date.issued2014
dc.description.abstractBackground and objective About 9% of gastric carcinomas have Epstein-Barr virus (EBV) in the tumour cells, but it is unclear whether viral presence influences clinical progression. We therefore examined a large multicentre case series for the association of tumour EBV status with survival after gastric cancer diagnosis, accounting for surgical stage and other prognostic factors.
dc.description.abstractMethods We combined individual-level data on 4599 gastric cancer patients diagnosed between 1976 and 2010 from 13 studies in Asia (n=8), Europe (n=3), and Latin America (n=2). EBV positivity of tumours was assessed by in situ hybridisation. Mortality HRs for EBV positivity were estimated by Cox regression models stratified by study, adjusted for distributions of sex (71% male), age (mean 58years), stage (52% tumour-node-metastasis stages III or IV), tumour histology (49% poorly differentiated, 57% Lauren intestinal-type), anatomic subsite (70% non-cardia) and year of diagnosis. Variations by study and continent were assessed using study-specific HRs for EBV positivity.
dc.description.abstractResults During median 3.0years follow-up, 49% of patients died. Stage was strongly predictive of mortality, with unadjusted HRs (vs stage I) of 3.1 for stage II, 8.1 for stage III and 13.2 for stage IV. Tumour EBV positivity was 8.2% overall and inversely associated with stage (adjusted OR: 0.79 per unit change). Adjusted for stage and other confounders, EBV positivity was associated with lower mortality (HR, 0.72; 95% CI 0.61 to 0.86), with low heterogeneity among the study populations (p=0.2). The association did not significantly vary across patient or tumour characteristics. There was no significant variation among the three continent-specific HRs (p=0.4).
dc.description.abstractConclusions Our findings suggest that tumour EBV positivity is an additional prognostic indicator in gastric cancer. Further studies are warranted to identify the mechanisms underlying this protective association.
dc.fuente.origenWOS
dc.identifier.doi10.1136/gutjnl-2013-304531
dc.identifier.eissn1468-3288
dc.identifier.issn0017-5749
dc.identifier.urihttps://doi.org/10.1136/gutjnl-2013-304531
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/101759
dc.identifier.wosidWOS:000329488100009
dc.issue.numero2
dc.language.isoen
dc.pagina.final243
dc.pagina.inicio236
dc.revistaGut
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleImproved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis
dc.typeartículo
dc.volumen63
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas